GRK (GPCRK)
G protein-coupled receptors (GPCRs) are the largest family of signaling proteins in animals. Among mammals, elephants hold the record with >3400 GPCR subtypes. GRKs belong to the AGC kinase super-family(named for protein kinases A, G, and C discovered earlier). Unlike the other AGC kinases, such as PKA or PKC, GRKs do not have a consensus phosphorylation site, but appear to phosphorylate various serines and threonines in the C-terminus and other cytoplasmic GPCR elements regardless of their sequence context. GRKs of the GRK2/3 subfamily apparently phosphorylate different serines and threonines than ubiquitous members of GRK4 subfamily, GRK5/6, as was directly demonstrated with some GPCRs or deduced from different functional consequences of this phosphorylation in case of other receptors. Another peculiarity of GRKs is that they are not activated by small molecules or the phosphorylation of the activation loop, but by physical interaction with activated GPCRs. GRKs have been reported to phosphorylate and thus regulate via phosphorylation numerous non-GPCR substrates, including receptor tyrosine kinases, single transmembrane domain serine/threonine kinases, death receptors, toll-like receptors, transcription factors, various adapter proteins, cytosolic, nuclear and cytoskeletal proteins.
References
1.Gurevich VV,et al. Front Pharmacol. 2019 Feb 19;10:125.
2.Gurevich VV,et al. Int J Mol Sci. 2017 Nov 24;18(12).
References
1.Gurevich VV,et al. Front Pharmacol. 2019 Feb 19;10:125.
2.Gurevich VV,et al. Int J Mol Sci. 2017 Nov 24;18(12).
Others
GRK (GPCRK)
-
GRK6-IN-1
catalog no : M35650
cas no: 2677786-61-5
GRK6-IN-1 (compound 18) is a potent inhibitor of G protein-coupled receptor kinase 6 (GRK6) with an IC50 of 120 nM, and has potential for study in multiple myeloma. -
GRK6-IN-2
catalog no : M35570
cas no: 2677786-27-3
GRK6-IN-2 is a potent G protein-coupled receptor kinase 6 (GRK6) inhibitor with potential antitumor activity.GRK6-IN-2 has been studied in multiple myeloma. -
GSK299115A
catalog no : M34272
cas no: 864082-35-9
GSK299115A (GSK-299115A) is a selective ROCK1 Inhibitor. GSK299115A exhibits IC50 of 8nM, 620nM, 560nM for ROCK1, RSK1, p70S6K, respectively. -
GSK270822A
catalog no : M34271
cas no: 864082-23-5
GSK270822A is a selective ROCK1 inhibitor. GSK270822A exhibits IC50 of 9nM, 1100nM, 1550nM for ROCK1, RSK1, p70S6K, respectively. -
GRK2i
catalog no : M30680
cas no: 148505-03-7
GRK2 inhibitory polypeptide that specifically inhibits Gβγ activation of GRK2. Corresponds to the Gβγ-binding domain and acts as a cellular Gβγ antagonist.